Clinical Trial Results:
Phase 2, randomised, open label, multicenter study of intradermal IMA901 plus GM-CSF with or without low dose cyclophosphamide pre-treatment in advanced renal cell carcinoma patients with measurable disease
Summary
|
|
EudraCT number |
2006-006370-25 |
Trial protocol |
DE SK GB AT HU ES BG |
Global completion date |
24 Aug 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
25 Apr 2018
|
First version publication date |
25 Apr 2018
|
Other versions |
|
Summary report(s) |
Synopsis Study Report IMA901-202 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.